The Swine Flu Pandemic: Public Health Policy and Maryland's Role in Vaccine Development
Each day brings more headlines and news reports of the burgeoning U.S. outbreaks of swine flu – the most serious influenza pandemic since the Spanish flu circled the globe in 1918. As government authorities at the Department of Health and Human Services (HHS) and the Food and Drug Administration (FDA) convened to develop the nation’s response to the pandemic, critical work being performed at Maryland’s preeminent academic institutions and within its bioscience industry has resulted in significant contributions to the creation of both public health policy and the development of a vaccine against the H1N1 virus.
Join us to hear these leaders and experts describe their work and answer your questions. Our distinguished speakers include:
John M. Colmers (invited)
Secretary, Department of Health and Mental Hygiene
State of Maryland
Professor Ruth A. Karron, M.D.
Director, Center for Immunization Research
Director, Johns Hopkins Vaccine Initiative
Johns Hopkins Bloomberg School of Public Health
Wilbur H. Chen, M.D.
Assistant Professor, Center for Vaccine Development
University of Maryland School of Medicine
Drs. Ben Machielse
Executive Vice President, Operations
Rahul Singhvi, Sc.D, MBA
President and CEO